Search research articles
Contact Us
Filters
Showing results (21-30 of 176) with videos related to
Page
of 18
Sort By:
Lancet (London, England)
|
September 23, 2008
The coming of age of asthma guidelines
R Andrew McIvor, Kenneth R Chapman
The Journal of Allergy and Clinical Immunology. in Practice
|
November 10, 2022
Triple Therapy of Asthma-Permutations and Combinations
Job F M van Boven, Kenneth R Chapman
Canadian Respiratory Journal
|
December 18, 2003
Diffuse panbronchiolitis in a Caucasian man in Canada
Alessandra Sandrini, M S Balter, Kenneth R Chapman
The Journal of Allergy and Clinical Immunology. in Practice
|
September 10, 2019
The Hidden Story of Nonadherence with Asthma Therapy: For a Few Dollars More?
Job F M van Boven, Kenneth R Chapman
American Journal of Respiratory and Critical Care Medicine
|
January 16, 2002
Assessment of a medication-based asthma index for population research
Wendy J Ungar, Kenneth R Chapman, Maria T Santos
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
September 21, 2013
Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries
David Price, Peter Dale, Emma Elder, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
July 5, 2012
Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease
Sarah K Brode, Simon C Ling, Kenneth R Chapman
Respiratory Medicine
|
February 21, 2016
Current thinking and new paradigm for COPD
Tobias Welte, Kenneth R Chapman, Helgo Magnussen, et al.
The Lancet. Respiratory Medicine
|
January 24, 2021
α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action
Chengliang Yang, Kenneth R Chapman, Aaron Wong, et al.
Treatments in Respiratory Medicine
|
February 24, 2005
Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
Raja T Abboud, Gordon T Ford, Kenneth R Chapman
Page
of 18
Search research articles
Search
Showing results (21-30 of 176) with videos related to
Sort By:
Page
of 18
Lancet (London, England)
|
September 23, 2008
The coming of age of asthma guidelines
R Andrew McIvor, Kenneth R Chapman
The Journal of Allergy and Clinical Immunology. in Practice
|
November 10, 2022
Triple Therapy of Asthma-Permutations and Combinations
Job F M van Boven, Kenneth R Chapman
Canadian Respiratory Journal
|
December 18, 2003
Diffuse panbronchiolitis in a Caucasian man in Canada
Alessandra Sandrini, M S Balter, Kenneth R Chapman
The Journal of Allergy and Clinical Immunology. in Practice
|
September 10, 2019
The Hidden Story of Nonadherence with Asthma Therapy: For a Few Dollars More?
Job F M van Boven, Kenneth R Chapman
American Journal of Respiratory and Critical Care Medicine
|
January 16, 2002
Assessment of a medication-based asthma index for population research
Wendy J Ungar, Kenneth R Chapman, Maria T Santos
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
September 21, 2013
Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries
David Price, Peter Dale, Emma Elder, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
July 5, 2012
Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease
Sarah K Brode, Simon C Ling, Kenneth R Chapman
Respiratory Medicine
|
February 21, 2016
Current thinking and new paradigm for COPD
Tobias Welte, Kenneth R Chapman, Helgo Magnussen, et al.
The Lancet. Respiratory Medicine
|
January 24, 2021
α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action
Chengliang Yang, Kenneth R Chapman, Aaron Wong, et al.
Treatments in Respiratory Medicine
|
February 24, 2005
Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
Raja T Abboud, Gordon T Ford, Kenneth R Chapman
Page
of 18